- Lower volatility than the market (beta -0.09)
- High gross margin of 70.7%
- Highly efficient cash conversion (102% FCF/OCF ratio)
Xilio Therapeutics, Inc. stock price ended at $8.34 on Monday, after gaining 0.361%
(Updated on Jun 15, 2026)
The Xilio Therapeutics, Inc. stock price gained 0.361% on the last trading day (Monday, 15th Jun 2026), rising from $8.31 to $8.34. It has now gained 3 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. During the last trading day the stock fluctuated 7.08% from a day low at $7.99 to a day high of $8.55. The price has risen in 5 of the last 10 days and is up by 1.09% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 49 thousand more shares were traded than the day before. In total, 61 thousand shares were bought and sold for approximately $510.27 thousand.
The stock is moving within a wide and horizontal trend and further movements within this trend can be expected. Given the current horizontal trend, you can expect Xilio Therapeutics, Inc. stock with a 90% probability to be traded between $7.65 and $8.76 at the end of this 3-month period. A break of a horizontal trend is often followed by a large increase in the volume, and stocks seldom manage to go directly from the bottom of a trend up to the top. Stocks turning up in the middle of a horizontal trend are therefore considered to be potential runners.
XLO Signals & Forecast
The Xilio Therapeutics, Inc. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock, but the stock has a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections down, there will be some support from the lines at $7.97 and $8.11. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Monday, June 08, 2026, and so far it has risen 8.59%. Further rise is indicated until a new top pivot has been found. Xilio Therapeutics, Inc. has increased volume and follows the last lift in the price. This is considered to be a technical positive sign as volume should follow the price-formation. Higher liquidity also reduces the general risk. Some negative signals were issued as well, and these may have some influence on the near short-term development. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).
Support, Risk & Stop-loss for Xilio Therapeutics, Inc. stock
Xilio Therapeutics, Inc. finds support from accumulated volume at $8.25 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.565 between high and low, or 7.08%. For the last week, the stock has had daily average volatility of 4.54%.
Our recommended stop-loss: $8.01 (-4.00%) (This stock has medium daily movements and this gives medium risk. There is a buy signal from a pivot bottom found 5 days ago.)
Trading Expectations (XLO) For The Upcoming Trading Day Of Tuesday 16th
For the upcoming trading day on Tuesday, 16th we expect Xilio Therapeutics, Inc. to open at $8.29, and during the day (based on 14 day Average True Range), to move between $8.14 and $8.54, which gives a possible trading interval of +/-$0.405 (+/-4.98%) up or down from last closing price. If Xilio Therapeutics, Inc. takes out the full calculated possible swing range there will be an estimated 4.98% move between the lowest and the highest trading price during the day.
Since the stock is closer to the resistance from accumulated volume at $8.37 (0.36%) than the support at $8.25 (1.08%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.
Is Xilio Therapeutics, Inc. stock A Buy?
Xilio Therapeutics, Inc. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.
Current score:
0.643
Hold/Accumulate
Unchanged
Predicted Fair Opening Price
Predicted fair opening price on June 16, 2026 - $8.29 ( 0.580%).
Want to trade but not sure how?
Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* 
*Your capital is at risk
XLO Performance
Trading levels for XLO
Fibonacci Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 8.86 | 6.20% |
| R2 | 8.64 | 3.61% |
| R1 | 8.51 | 2.01% |
| Price | 8.34 | |
| S1 | 8.08 | -3.17% |
| S2 | 7.94 | -4.77% |
| S3 | 7.73 | -7.35% |
Accumulated Volume Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 8.81 | 5.64% |
| R2 | 8.46 | 1.44% |
| R1 | 8.37 | 0.360% |
| Price | 8.34 | |
| S1 | 8.25 | -1.08% |
| S2 | 7.86 | -5.76% |
| S3 | 7.66 | -8.15% |
FAQ
Click here for our free guide on how to buy Xilio Therapeutics, Inc. Stock.
Buy XLO
A buy signal from a double bottom formation was found on Monday, June 08, 2026 and based on theory for this formation the price should go up by 8.94% to $9.09 within 23 trading days (Monday, July 13, 2026) since signal was issued.